))
Protect Your Heart
Manage episode 454034740 series 2849626
Sisällön tarjoaa BEaTS Research Radio. BEaTS Research Radio tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Anastasia Fahlman and Sarah Damiani from the University of Ottawa speak with Dr. Erin Mulvihill, Scientist and Director of the Energy Substrate Metabolism Research Laboratory at the University of Ottawa Heart Institute. Tune in to learn more about her recent work published in CellPress, which explores the potential mechanisms underlying the cardioprotective benefits of metabolic surgery and GLP-1RA-based therapies. It also discusses recent evidence and emerging therapies in this dynamic area of research.
Learn more: https://www.sciencedirect.com/science/article/pii/S1043276024001930
Credits for music: Soundtracks by the Underground Drive. All rights reserved. Listen more:
https://music.apple.com/ca/artist/the-underground-drive/1571062779
https://open.spotify.com/artist/4sCJG8TMQyTZ9FDd1JjJmR
Podcast by Sarah Damiani (Voice, Producer, Show Co-Host, Writer Editor, Audio Master) and Anastasia Fahlman (Voice, Show Co-Host, Writer Editor, Audio Master)
Luvut
1. Protect Your Heart (00:00:00)
2. Introduction (00:00:07)
3. Overview of Dr. Mulvihill’s Research (00:00:52)
4. Ethical and Medical Concerns of using GLP1-RAs for Non-Medical Reasons (00:01:40)
5. How GLP1-RAs has changed the treatment of Type 2 Diabetes (00:03:10)
6. Long term impacts of GLP1-RA therapy (00:04:43)
7. Future topics of research to better patient outcomes and quality of life (00:06:12)
8. Synthesis of information for scientific community for new hypothesis (00:07:23)
9. The gap in knowledge for women in GLP1-RA therapy research (00:09:00)
10. Patient experiences with GLP1-RA therapies (00:10:20)
11. Conclusion and thanks (00:12:21)
31 jaksoa
Jaa
